About Dopa-responsive dystonia due to sepiapterin reductase deficiency
Dopa-responsive dystonia due to sepiapterin reductase deficiency is a rare disease catalogued by Orphanet (ORPHA:70594). It is associated with the SPR gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Dopa-responsive dystonia due to sepiapterin reductase deficiency trials.
Search ClinicalTrials.gov for "Dopa-responsive dystonia due to sepiapterin reductase deficiency" or filter by Orphanet code ORPHA:70594 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Dopa-responsive dystonia due to sepiapterin reductase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Dopa-responsive dystonia due to sepiapterin reductase deficiency. Updated daily.